Novel neurosteroid anesthetics and perioperative analgesia
新型神经类固醇麻醉剂和围手术期镇痛
基本信息
- 批准号:9926278
- 负责人:
- 金额:$ 34.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:Absence of pain sensationAcuteAcute PainAfferent NeuronsAnalgesicsAndrostanolsAnestheticsBiophysical ProcessCalciumCalcium ChannelCalcium Channel BlockersCellsChronicCocaineConstipationDataDiseaseDoseDrug abuseElectron MicroscopyFutureGeneral anesthetic drugsGoalsHeroinHomeostasisHumanImmunohistochemistryImpaired cognitionIn VitroInjectableKnockout MiceKnowledgeLaboratoriesLeadMediatingMedicalModalityModelingMusNarcoticsNeuronsNociceptionNociceptorsOperative Surgical ProceduresOpioidOpioid AnalgesicsOutcomePainPain managementPathway interactionsPerioperativePeripheralPharmaceutical PreparationsPharmacologyPosterior Horn CellsPostoperative PainPostoperative PeriodPreparationPresynaptic TerminalsPropertyRattusRecombinantsResearchRodent ModelRoleSensory Motor PerformancesSiteSkinSliceSpinalSpinal CordSpinal GangliaSpinal cord posterior hornSteroidsStructure-Activity RelationshipSurgical incisionsSynapsesSynaptic TransmissionSynaptic VesiclesT-Type Calcium ChannelsTestingTissuesUnited StatesUnited States National Center for Health StatisticsUrinary RetentionVentilatory DepressionWorkaddictionchronic painful conditionclinically relevantcognitive functiondesigndorsal hornexpectationexperimental studyganglion cellhypnoticin vivoinhibitor/antagonistinnovationneuronal excitabilityneurophysiologyneurosteroidsnovelnovel therapeuticsopioid abuseoverdose deathpain processingpatch clampresponseside effectsoft tissuesteroid analogtissue injuryvoltage
项目摘要
Project Summary
Pain-sensing sensory neurons of the dorsal root ganglion (DRG) and dorsal horn (DH) can become sensitized
(hyperexcitable) in response to surgically induced peripheral tissue injury. Because of insufficient knowledge
about the mechanisms for this sensitization, current treatment for postoperative pain has been limited to
somewhat non-specific systemic drugs (opioids) having significant side effects or potential for abuse. Recent
studies in our laboratory have established that CaV3.2 (T-type) calcium-channels and CaV2.3 (R-type) voltage-
gated calcium channels make a previously unrecognized contribution to sensitization of pain responses by
enhancing excitability of peripheral nociceptors and controlling excitatory synaptic transmission in the DH of
the spinal cord. We previously showed that the blockade of CaV3.2 currents in nociceptive DRG neurons by
5β-reduced neuroactive steroids underlies their potent peripheral anti-nociceptive effects. Our new data
demonstrate that one such steroid, 3β-OH [(3β,5β,17β)-3-hydroxyandrostane-17-carbonitrile], in addition to
hypnotic properties, also displays excellent spinally-mediated analgesia. We also found that 3β-OH inhibits
recombinant CaV2.3 currents. This finding has led us to hypothesize that: inhibition of neuronal CaV3.2 and
CaV2.3 currents in pain pathways with the novel anesthetic 3β-OH and related neuroactive steroids underlies
effective analgesia. In Aim 1, we will study analgesic potency of neuroactive steroids using a clinically relevant
rodent model of skin and deep tissue incision. In Aim 2, we will define the role of neuroactive steroids in
modulating synaptic transmission and neuronal excitability of nociceptive DH neurons. These studies will
define the whole-cell neurophysiological effects of test compounds in the major nociceptive pathway. We will
also use electron microscopy to study cellular and subcellular localization of CaV2.3 and CaV3.2 channels in
nociceptive DH neurons. In Aim 3, we will study mechanisms and structure-activity relationships of steroid
inhibition of recombinant and native CaV2.3 currents in the nociceptive DRG neurons. The main goal of this
aim is to expand the limited information currently available with the expectation that the information obtained
will be important for the design of more potent and selective inhibitors of CaV2.3 channels that can be
important in developing novel and safer anesthetics and analgesics. The proposed work is innovative and
medically significant because we anticipate that our studies will identify novel therapies for perioperative pain
that may greatly decrease the need for narcotics and potential for drug abuse.β
项目摘要
背根神经节(DRG)和背角(DH)的痛觉神经元可被致敏
(过度兴奋的)响应于手术诱导的外周组织损伤。由于知识不足
关于这种致敏的机制,目前对术后疼痛的治疗仅限于
具有显著副作用或滥用可能性的某种非特异性全身性药物(阿片类药物)。最近
我们实验室的研究已经确定,CaV3.2(T型)钙通道和CaV2.3(R型)电压-
门控钙通道对疼痛反应的敏感性做出了以前未被认识的贡献,
增强外周伤害感受器的兴奋性并控制DH中的兴奋性突触传递,
脊髓我们以前发现,阻断伤害性DRG神经元的CaV3.2电流,
5β-还原的神经活性类固醇是其有效的外周抗伤害感受作用的基础。我们的新数据
证明了一种这样的类固醇,3β-OH [(3β,5 β,17 β)-3-羟基雄甾烷-17-腈],除了
催眠性质,也显示出优异的脊髓介导的镇痛作用。我们还发现3β-OH抑制
重组CaV2.3电流。这一发现使我们假设:抑制神经元CaV3.2和
新型麻醉剂3β-OH和相关神经活性类固醇在疼痛通路中的CaV2.3电流
有效的镇痛。在目标1中,我们将使用临床相关的方法研究神经活性类固醇的镇痛效力。
皮肤和深部组织切口的啮齿动物模型。在目标2中,我们将定义神经活性类固醇在以下方面的作用:
调节伤害感受性DH神经元的突触传递和神经元兴奋性。这些研究将
定义了测试化合物在主要伤害感受途径中的全细胞神经生理学作用。我们将
我们还使用电子显微镜研究了CaV2.3和CaV3.2通道的细胞和亚细胞定位,
伤害感受性DH神经元。目的三是研究甾体类化合物的作用机制和构效关系
在伤害感受性DRG神经元中的重组和天然CaV2.3电流的抑制。这个的主要目标
目的是扩大目前可用的有限信息,并期望获得的信息
对于设计更有效和选择性的CaV2.3通道抑制剂非常重要,
在开发新的和更安全的麻醉剂和镇痛剂方面具有重要意义。这项工作具有创新性,
具有医学意义,因为我们预计我们的研究将确定围手术期疼痛的新疗法
这可能会大大减少对麻醉品的需求和药物滥用的可能性。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Preemptive Analgesic Effect of Intrathecal Applications of Neuroactive Steroids in a Rodent Model of Post-Surgical Pain: Evidence for the Role of T-Type Calcium Channels.
- DOI:10.3390/cells9122674
- 发表时间:2020-12-12
- 期刊:
- 影响因子:6
- 作者:Tat QL;Joksimovic SM;Krishnan K;Covey DF;Todorovic SM;Jevtovic-Todorovic V
- 通讯作者:Jevtovic-Todorovic V
Neurosteroids in Pain Management: A New Perspective on an Old Player.
- DOI:10.3389/fphar.2018.01127
- 发表时间:2018
- 期刊:
- 影响因子:5.6
- 作者:Joksimovic SL;Covey DF;Jevtovic-Todorovic V;Todorovic SM
- 通讯作者:Todorovic SM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vesna Jevtovic-Todorovic其他文献
Vesna Jevtovic-Todorovic的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vesna Jevtovic-Todorovic', 18)}}的其他基金
Novel neurosteroid anesthetics and developmental synaptogenesis
新型神经类固醇麻醉剂和发育突触发生
- 批准号:
10201697 - 财政年份:2019
- 资助金额:
$ 34.23万 - 项目类别:
Novel neurosteroid anesthetics and developmental synaptogenesis
新型神经类固醇麻醉剂和发育突触发生
- 批准号:
10673850 - 财政年份:2019
- 资助金额:
$ 34.23万 - 项目类别:
Novel neurosteroid anesthetics and developmental synaptogenesis
新型神经类固醇麻醉剂和发育突触发生
- 批准号:
10456624 - 财政年份:2019
- 资助金额:
$ 34.23万 - 项目类别:
Novel neurosteroid anesthetics and developmental synaptogenesis
新型神经类固醇麻醉剂和发育突触发生
- 批准号:
10017289 - 财政年份:2019
- 资助金额:
$ 34.23万 - 项目类别:
Novel neurosteroid anesthetics and perioperative analgesia
新型神经类固醇麻醉剂和围手术期镇痛
- 批准号:
9333664 - 财政年份:2017
- 资助金额:
$ 34.23万 - 项目类别:
Molecular mechanisms of glycosylation of Cav3.2 channels in pain pathway
疼痛通路中Cav3.2通道糖基化的分子机制
- 批准号:
9127411 - 财政年份:2016
- 资助金额:
$ 34.23万 - 项目类别:
Molecular mechanisms of glycosylation of Cav3.2 channels in pain pathway
疼痛通路中Cav3.2通道糖基化的分子机制
- 批准号:
9471872 - 财政年份:2016
- 资助金额:
$ 34.23万 - 项目类别:
相似海外基金
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
- 批准号:
10603436 - 财政年份:2023
- 资助金额:
$ 34.23万 - 项目类别:
Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and young Children (COA APTIC)
婴幼儿急性疼痛治疗的临床结果评估 (COA APTIC)
- 批准号:
10778757 - 财政年份:2023
- 资助金额:
$ 34.23万 - 项目类别:
Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and young Children (COA APTIC)
婴幼儿急性疼痛治疗的临床结果评估 (COA APTIC)
- 批准号:
10783106 - 财政年份:2023
- 资助金额:
$ 34.23万 - 项目类别:
Development of A Focused Ultrasound Device for Noninvasive, Peripheral Nerve Blockade to Manage Acute Pain
开发用于非侵入性周围神经阻断来治疗急性疼痛的聚焦超声装置
- 批准号:
10740796 - 财政年份:2023
- 资助金额:
$ 34.23万 - 项目类别:
Predicting Pediatric Sickle Cell Disease Acute Pain Using Mathematical Models Based on mHealth Data
使用基于移动健康数据的数学模型预测儿童镰状细胞病急性疼痛
- 批准号:
10599401 - 财政年份:2022
- 资助金额:
$ 34.23万 - 项目类别:
Non-Contingent Acute Pain Stress Drives Analgesic Protection in Rats.
非偶然急性疼痛应激驱动大鼠镇痛保护。
- 批准号:
575854-2022 - 财政年份:2022
- 资助金额:
$ 34.23万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Prefrontal Cortex Hemodynamic Responses to Mindfulness Meditation and Acute Pain
前额皮质血流动力学对正念冥想和急性疼痛的反应
- 批准号:
467076 - 财政年份:2021
- 资助金额:
$ 34.23万 - 项目类别:
Studentship Programs
A Multimodal Approach for Monitoring Prolonged Acute Pain in Neonates
监测新生儿长期急性疼痛的多模式方法
- 批准号:
9979265 - 财政年份:2020
- 资助金额:
$ 34.23万 - 项目类别:
A Multimodal Approach for Monitoring Prolonged Acute Pain in Neonates
监测新生儿长期急性疼痛的多模式方法
- 批准号:
10218273 - 财政年份:2020
- 资助金额:
$ 34.23万 - 项目类别: